FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease
Summary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…